Bleeding Complications in Patients Undergoing Percutaneous Coronary Intervention

被引：31

作者：

Galli, Mattia ^{[1
,2
]}

Laborante, Renzo ^{[1
]}

Andreotti, Felicita ^{[1
,3
]}

Vergallo, Rocco ^{[3
]}

Montone, Rocco Antonio ^{[3
]}

Iaconelli, Antonio ^{[3
]}

Trani, Carlo ^{[1
,3
]}

Burzotta, Francesco ^{[1
,3
]}

Crea, Filippo ^{[1
,3
]}

D'Amario, Domenico ^{[3
]}

机构：

[1] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, I-00168 Rome, Italy

[2] GVM Care & Res, Maria Cecilia Hosp, Dept Cardiol, I-48033 Cotignola, Italy

[3] Fdn Policlin Univ A Gemelli, Dept Cardiovasc Med, IRCCS, I-00168 Rome, Italy

来源：

REVIEWS IN CARDIOVASCULAR MEDICINE | 2022年 / 23卷 / 08期

关键词：

percutaneous coronary interventions; bleeding; complications; antithrombotic therapy; ST-SEGMENT-ELEVATION; DRUG-ELUTING STENTS; ACUTE MYOCARDIAL-INFARCTION; DUAL ANTIPLATELET THERAPY; ARTERY-DISEASE; RISK STRATIFICATION; ATRIAL-FIBRILLATION; P2Y(12) INHIBITORS; CLINICAL-OUTCOMES; ELDERLY-PATIENTS;

D O I：

10.31083/j.rcm2308286

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Percutaneous coronary intervention (PCI) is considered a relatively safe procedure associated with low rates of complications, but is inevitably associated with short and mid-to-long term increased bleeding risk. Besides the short term risk associated with the arterial access to perform PCI, enhanced bleeding risk persists for several months, given the need for antithrombotic therapy to prevent procedurerelated thrombotic complications as well as ischemic recurrences. Bleeding is a powerful harbinger of adverse outcomes. This awareness has fuelled intense research on bleeding reduction strategies, including new PCI devices and techniques as well as new medications and antithrombotic regimens. We here review the mechanisms and prevalence of bleeding in PCI patients, discuss the available evidence from a practical point of view, and explore future perspectives on how to treat and prevent bleeding complications in these patients.

引用

页数：23

共 108 条

[61] Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome The TICO Randomized Clinical Trial [J].

Kim, Byeong-Keuk ;

Hong, Sung-Jin ;

Cho, Yun-Hyeong ;

Yun, Kyeong Ho ;

Kim, Yong Hoon ;

Suh, Yongsung ;

Cho, Jae Young ;

Her, Ae-Young ;

Cho, Sungsoo ;

Jeon, Dong Woon ;

Yoo, Sang-Yong ;

Cho, Deok-Kyu ;

Hong, Bum-Kee ;

Kwon, Hyuckmoon ;

Ahn, Chul-Min ;

Shin, Dong-Ho ;

Nam, Chung-Mo ;

Kim, Jung-Sun ;

Ko, Young-Guk ;

Choi, Donghoon ;

Hong, Myeong-Ki ;

Jang, Yangsoo .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (23) :2407-2416

[62] 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) [J].

Knuuti, Juhani ;

Wijns, William ;

Saraste, Antti ;

Capodanno, Davide ;

Barbato, Emanuele ;

Funck-Brentano, Christian ;

Prescott, Eva ;

Storey, Robert F. ;

Deaton, Christi ;

Cuisset, Thomas ;

Agewall, Stefan ;

Dickstein, Kenneth ;

Edvardsen, Thor ;

Escaned, Javier ;

Gersh, Bernard J. ;

Svitil, Pavel ;

Gilard, Martine ;

Hasdai, David ;

Hatala, Robert ;

Mahfoud, Felix ;

Masip, Josep ;

Muneretto, Claudio ;

Valgimigli, Marco ;

Achenbach, Stephan ;

Bax, Jeroen J. ;

Neumann, Franz-Josef ;

Sechtem, Udo ;

Banning, Adrian Paul ;

Bonaros, Nikolaos ;

Bueno, Hector ;

Bugiardini, Raffaele ;

Chieffo, Alaide ;

Crea, Filippo ;

Czerny, Martin ;

Delgado, Victoria ;

Dendale, Paul .

EUROPEAN HEART JOURNAL, 2020, 41 (03) :407-477

[63] Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD The ASET Pilot Study [J].

Kogame, Norihiro ;

Guimaraes, Patricia O. ;

Modolo, Rodrigo ;

De Martino, Fernando ;

Tinoco, Joao ;

Ribeiro, Expedito E. ;

Kawashima, Hideyuki ;

Ono, Masafumi ;

Hara, Hironori ;

Wang, Rutao ;

Cavalcante, Rafael ;

Moulin, Bruno ;

Falcao, Breno A. A. ;

Leite, Rogerio S. ;

de Almeida Sampaio, Fernanda Barbosa ;

Morais, Gustavo R. ;

Meireles, George C. ;

Campos, Carlos M. ;

Onuma, Yoshinobu ;

Serruys, Patrick W. ;

Lemos, Pedro A. .

JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (19) :2251-2262

[64] 1-Year Safety of 3-Month Dual Antiplatelet Therapy Followed by Aspirin or P2Y12 Receptor Inhibitor Monotherapy Using a Bioabsorbable Polymer Sirolimus-Eluting Stent [J].

Kozuma, Ken ;

Kinoshita, Yoshihisa ;

Hioki, Hirofumi ;

Nanasato, Mamoru ;

Ito, Yoshiaki ;

Yamaguchi, Junichi ;

Shiode, Nobuo ;

Hibi, Kiyoshi ;

Tanabe, Kengo ;

Ako, Junya ;

Morino, Yoshihiro ;

Hirohata, Atsushi ;

Sonoda, Shinjo ;

Nakagawa, Yoshihisa ;

Ikari, Yuji .

CIRCULATION JOURNAL, 2021, 85 (01) :19-+

[65] Reversal agents for non-vitamin K antagonist oral anticoagulants [J].

Levy, Jerrold H. ;

Douketis, James ;

Weitz, Jeffrey I. .

NATURE REVIEWS CARDIOLOGY, 2018, 15 (05) :273-281

[66] Optimal Antithrombotic Regimens for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention An Updated Network Meta-analysis [J].

Lopes, Renato D. ;

Hong, Hwanhee ;

Harskamp, Ralf E. ;

Bhatt, Deepak L. ;

Mehran, Roxana ;

Cannon, Christopher P. ;

Granger, Christopher B. ;

Verheugt, Freek W. A. ;

Li, Jianghao ;

ten Berg, Jurrien M. ;

Sarafoff, Nikolaus ;

Vranckx, Pascal ;

Goette, Andreas ;

Gibson, C. Michael ;

Alexander, John H. .

JAMA CARDIOLOGY, 2020, 5 (05) :582-589

[67] 3-or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation [J].

Mehran, Roxana ;

Cao, Davide ;

Angiolillo, Dominick J. ;

Bangalore, Sripal ;

Bhatt, Deepak L. ;

Ge, Junbo ;

Hermiller, James ;

Makkar, Raj R. ;

Neumann, Franz-Josef ;

Saito, Shigeru ;

Picon, Hector ;

Toelg, Ralph ;

Maksoud, Aziz ;

Chehab, Bassem M. ;

De la Torre Hernandez, Jose M. ;

Kunadian, Vijay ;

Sardella, Gennaro ;

Thiele, Holger ;

Varenne, Olivier ;

Vranckx, Pascal ;

Windecker, Stephan ;

Zhou, Yujie ;

Krucoff, Mitchell W. ;

Ruster, Karine ;

Wang, Jin ;

Valgimigli, Marco .

JACC-CARDIOVASCULAR INTERVENTIONS, 2021, 14 (17) :1870-1883

[68] Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study [J].

Mehran, Roxana ;

Baber, Usman ;

Steg, Philippe Gabriel ;

Ariti, Cono ;

Weisz, Giora ;

Witzenbichler, Bernhard ;

Henry, Timothy D. ;

Kini, Annapoorna S. ;

Stuckey, Thomas ;

Cohen, David J. ;

Berger, Peter B. ;

Iakovou, Ioannis ;

Dangas, George ;

Waksman, Ron ;

Antoniucci, David ;

Sartori, Samantha ;

Krucoff, Mitchell W. ;

Hermiller, James B. ;

Shawl, Fayaz ;

Gibson, C. Michael ;

Chieffo, Alaide ;

Alu, Maria ;

Moliterno, David J. ;

Colombo, Antonio ;

Pocock, Stuart .

LANCET, 2013, 382 (9906) :1714-1722

[69] Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium [J].

Mehran, Roxana ;

Rao, Sunil V. ;

Bhatt, Deepak L. ;

Gibson, C. Michael ;

Caixeta, Adriano ;

Eikelboom, John ;

Kaul, Sanjay ;

Wiviott, Stephen D. ;

Menon, Venu ;

Nikolsky, Eugenia ;

Serebruany, Victor ;

Valgimigli, Marco ;

Vranckx, Pascal ;

Taggart, David ;

Sabik, Joseph F. ;

Cutlip, Donald E. ;

Krucoff, Mitchell W. ;

Ohman, E. Magnus ;

Steg, Philippe Gabriel ;

White, Harvey .

CIRCULATION, 2011, 123 (23) :2736-U144

[70] Targeting the safe zone: A quality improvement project to reduce vascular access complications [J].

Mignatti, Andrea ;

Friedmann, Patricia ;

Slovut, David Paul .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (01) :27-32

← 2 3 4 5 6 7 8 9 10 11 →